Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bortezomib and Topotecan Hydrochloride in Treating Patients With Advanced Solid Tumors

This study has been completed.
Information provided by (Responsible Party):
City of Hope Medical Center Identifier:
First received: October 5, 2007
Last updated: June 3, 2015
Last verified: June 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2011
  Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)